|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Product revenue, net | |||||
| License and collaboration revenue | |||||
| Total revenue | |||||
| Operating expenses: | |||||
| Cost of goods sold | |||||
| Product revenue, net | |||||
| License and collaboration revenue | |||||
| Total cost of goods sold | |||||
| Collaboration expenses | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Total operating expenses | |||||
| Income (loss) from operations | |||||
| Interest income (expense) | |||||
| Other income, net | |||||
| Income (loss) before income taxes | |||||
| Benefit (provision) for income taxes | |||||
| Net income (loss) | |||||
| Other comprehensive income (loss): | |||||
| Unrealized gain (loss) on short-term investments and currency translation adjustments, net of tax | |||||
| Total other comprehensive income (loss) | |||||
| Total comprehensive income (loss) | |||||
| Net income (loss) per share attributable to ordinary shareholders, basic | |||||
| Net income (loss) per share attributable to ordinary shareholders, diluted | |||||
| Weighted average ordinary shares outstanding, basic | |||||
| Weighted average ordinary shares outstanding, diluted |
Loading...